Veldhuyzen van Zanten S J, Pollak P T, Kapoor H, Yeung P K
Division of Gastroenterology, Faculty of Medicine, Dalhousie University, Victoria General Hospital, Halifax, Nova Scotia, Canada.
Dig Dis Sci. 1996 Sep;41(9):1845-52. doi: 10.1007/BF02088756.
Four healthy, Helicobacter-negative volunteers were studied to determine the effect of omeprazole on the movement of metronidazole across the gastric mucosa into the gastric lumen. Each received a 500-mg intravenous infusion of metronidazole and repeated serum, and gastric juice samples were obtained concomitantly over an 8-hr study via indwelling intravenous catheter and nasogastric tube. The same protocol was repeated following one week of oral omeprazole 20 mg twice daily. Metronidazole concentrations were measured by high-performance liquid chromatography. The results demonstrated that: metronidazole moves rapidly from serum into gastric juice; omeprazole causes a marked reduction in total metronidazole concentrations in gastric juice, completely accounted for by pH-related shifts in the proportion of ionized metronidazole, but does not alter concentrations of nonionized metronidazole, which remain above the MIC level against H. pylori; and even under conditions where no pH-related drug trapping occurs (pH > 4), concentrations of metronidazole were higher in gastric juice than in serum during most of the study, indicating that a special transport mechanism may be operational. The practical implication of this effect of omeprazole in combination therapy with metronidazole remains to be established.
对4名健康的、幽门螺杆菌阴性的志愿者进行了研究,以确定奥美拉唑对甲硝唑穿过胃黏膜进入胃腔的影响。每位志愿者接受了500毫克甲硝唑静脉输注,并在8小时的研究过程中,通过留置静脉导管和鼻胃管同时采集重复的血清和胃液样本。在每天口服两次20毫克奥美拉唑一周后,重复相同的方案。通过高效液相色谱法测量甲硝唑浓度。结果表明:甲硝唑从血清迅速转移到胃液中;奥美拉唑导致胃液中甲硝唑总浓度显著降低,这完全是由离子化甲硝唑比例的pH相关变化引起的,但不会改变非离子化甲硝唑的浓度,其浓度仍高于对幽门螺杆菌的最低抑菌浓度水平;即使在没有pH相关药物滞留的情况下(pH>4),在研究的大部分时间里,胃液中甲硝唑的浓度仍高于血清中的浓度,这表明可能存在一种特殊的转运机制。奥美拉唑在与甲硝唑联合治疗中的这种作用的实际意义仍有待确定。